Results 151 to 160 of about 2,042,286 (309)

Prognostic factors and long‐term outcome in dogs diagnosed with primary and secondary immune thrombocytopenia in Ireland

Journal of Small Animal Practice, Volume 66, Issue 5, Page 305-313, May 2025.
Objectives The objectives of this study were to describe the outcome and prognostic factors in dogs diagnosed with primary and secondary immune thrombocytopenia (ITP). Materials and Methods Medical records of dogs diagnosed with primary and secondary ITP in a referral hospital in Ireland were retrospectively evaluated.
E. López‐Bailén, A. Duclos, D. Mullany, K. Le Boedec, B. Cuq   +4 more
wiley   +1 more source

Severe fever with thrombocytopenia syndrome in China [PDF]

The Lancet Infectious Diseases, 2018
Meihua Yan, Wenquan Niu
openaire   +2 more sources

‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis

BJU International, EarlyView.
Lu Dongming, Ye Shuchao, Xie Xueping, Zheng Luoping, Liao Shangfan, Wu Yongyang   +5 more
wiley   +1 more source

Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission

Veterinary and Comparative Oncology, Volume 23, Issue 2, Page 236-245, June 2025.
ABSTRACT An optimal protocol of adding wide‐field irradiation to multi‐agent chemotherapy for dogs with lymphoma has not been established. The aim of this retrospective case–control study was to evaluate the efficacy of a protocol combining chemotherapy and half‐body irradiation (HBI) for dogs with high‐grade lymphoma.
Yen‐Hao Erik Lai, Sarah Lyles, Mark Mitchell, Jayme Looper   +3 more
wiley   +1 more source

Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study

International Journal of Infectious Diseases, 2021
Objectives: Invasive pulmonary aspergillosis (IPA) usually occurs in immunocompromised hosts. It has recently been reported that patients with severe fever with thrombocytopenia syndrome (SFTS) can also develop IPA. The aim of this study was to determine
Ying Xu, Mingran Shao, Ning Liu, Jian Tang, Qin Gu, Danjiang Dong   +5 more
doaj  

Francisella tularensis Transmission by Solid Organ Transplantation, 20171. [PDF]

, 2019
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died.
Annambhotla, Pallavi, Asad, Shadaba, Aslam, Saima, Basavaraju, Sridhar V, Brown, Jennifer, Burns, Kevin, Carifo, Karen, Dagher, Hikmat N, Fritz, Curtis L, Gonzalez, Anthony, Ham, John, Helsel, Elizabeth, Hinckley, Alison F, Iser, Joseph, Johnson, Michael, Jones, Jefferson M, Kelley, Walter E, Kingry, Luke C, Krafft, Melissa, Kwit, Natalie A, Medina-Garcia, Luis H, Mohler, Kelli, Murua, Christian, Nelson, Christina A, Petersen, Jeannine M, Respicio-Kingry, Laurel, Tularemia in Transplant Recipients Investigation Team, Wiggins, Landon, Zhang, Ying   +28 more
core  

Structure of Severe Fever with Thrombocytopenia Syndrome Virus Nucleocapsid Protein in Complex with Suramin Reveals Therapeutic Potential [PDF]

, 2013
Lianying Jiao, Songying Ouyang, Mifang Liang, Fengfeng Niu, Neil Shaw, Wei Wu, Wei Ding, Cong Jin, Yao Peng, Yanping Zhu, Fushun Zhang, Tao Wang, Chuan Li, Xiaobing Zuo, Chi-Hao Luan, Dexin Li, Zhi‐Jie Liu   +16 more
openalex   +1 more source

Architecture of severe fever with thrombocytopenia syndrome virus

Protein & Cell, 2023
Zixian Sun, Jing Cheng, Yuan Bai, Lin Cao, Daoxin Xie, Fei Deng, Xinzheng Zhang, Zihe Rao, Zhiyong Lou   +8 more
openaire   +2 more sources

Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma (TRUST): A Multicenter, Single‐Arm, Phase 2 Trial

Cancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background Histone deacetylase (HDAC) inhibitors demonstrated a synergistic anti‐tumor effect with rituximab and chemotherapy in preclinical studies on diffuse large B‐cell lymphoma (DLBCL). This phase 2 trial aimed to evaluate the efficacy and safety of chidamide, an orally active HDAC inhibitor, plus the R‐GemOx regimen for relapsed ...
Qihua Zou, Yuchen Zhang, Hui Zhou, Yulin Lai, Yi Cao, Zhiming Li, Ning Su, Wenyu Li, Huiqiang Huang, Panpan Liu, Xu Ye, Yudan Wu, Huo Tan, Runhui Zheng, Bingyi Wu, Hui Yang, Liye Zhong, Yuhong Lu, Yang Liang, Peng Sun, Lirong Li, Yingxian Liu, Danling Dai, Yi Xia, Qingqing Cai   +24 more
wiley   +1 more source

Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome [PDF]

, 2013
Won Sup Oh, Sang Taek Heo, Sun Hyung Kim, Won Jun Choi, Myung Guk Han, Ji Young Kim   +5 more
openalex   +1 more source